Clinical Trial Details
| Trial ID: | L0023 |
| Source ID: | NCT02029586 |
| Associated Drug: | MB12066 |
| Title: | Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis |
| Acronym: | -- |
| Status: | Terminated |
| Study Results: | No Results Available |
| Results: | -- |
| Conditions: | Nonalcoholic Fatty Liver Disease |
| Interventions: | Drug: MB12066 200mg|Drug: Placebo |
| Outcome Measures: | Change in hepatic steatosis(%)|Proportion of subjects with more than 1 point in total NAFLD Activity Score (NAS)|Change in fibrosis score|Change in steatosis score|Change in lobular inflammation score|Change in ballooning score|Change in lipid profile |
| Sponsor/Collaborators: | Yungjin Pharm. Co., Ltd. |
| Gender: | Male |
| Age: | 20 Years and older ?? (Adult, Older Adult) |
| Phases: | Phase 2 |
| Enrollment: | 18 |
| Study Type: | Interventional |
| Study Designs: | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment |
| Start Date: | January 2013 |
| Completion Date: | November 2014 |
| Results First Posted: | -- |
| Last Update Posted: | December 21, 2017 |
| Locations: | Seoul St. Mary's Hospital, Seoul, Banpo-daero Seocho-gu, Korea, Republic of|Uijeongbu St. Mary's Hospital, Uijeongbu, Cheonbo-ro Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Daehak-ro Jongno-gu, Korea, Republic of|Keimyung University Donsan Medical Center, Daegu, Dalseong-ro Jung-gu, Korea, Republic of|Kyungpook National University Hospital, Daegu, Dongdeok-ro Jung-gu, Korea, Republic of|Chung-ang University Hospital, Seoul, Heukseok-dong Dongjak-gu, Korea, Republic of|ASAN Medical Center, Seoul, Olympic-ro 43-gil, Songpa-gu, Korea, Republic of|Boramae Hospital, Seoul, Sindaebang-dong Dongjak-gu, Korea, Republic of|Hanyang University Medical Center, Seoul, Wangsimni-ro Seongdong-gu, Korea, Republic of|Severance Hospital, Seoul, Yonsei-ro Seodaemun-gu, Korea, Republic of |
| URL: | https://ClinicalTrials.gov/show/NCT02029586 |
